Animal Biotechnology Market to Reach $48.36 Billion by 2029, Growing at a CAGR of 10.1%

November 12, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Animal Biotechnology Industry In 2025?

The animal biotechnology market size has demonstrated robust growth in recent years. It is anticipated to increase from $30.33 billion in 2024 to $32.89 billion in 2025, progressing at a compound annual growth rate (CAGR) of 8.5%. The expansion observed in the historical period can be ascribed to factors including genetic improvement, enhanced agricultural productivity, the development of vaccines and therapeutics, initiatives for environmental sustainability, advancements in feed efficiency, nutritional enhancement, and a reduced environmental impact.

The animal biotechnology market is anticipated to experience substantial growth in the upcoming years, with its size expected to reach $48.36 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.1%. This expansion over the forecast period is driven by factors such as the development of disease-resistant strains, the production of biopharmaceuticals, advancements in cell-based meat production, mounting global food security concerns, increasing regulatory support, and growing public and consumer acceptance. Significant trends during this period are projected to include genome editing technologies, animal stem cell technology, the production of biopharmaceutical products in animals, efforts in biobanking and genetic resource preservation, the emergence of Crispr-based therapies, and improved biosecurity and disease surveillance.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8059&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Animal Biotechnology Industry?

The increasing understanding of animal health and welfare is projected to fuel the animal biotechnology market moving forward. Animal health and welfare relate to how individuals interact with animals and their duty to guarantee that animals under their supervision are handled appropriately and compassionately. In the context of animal health and welfare, animal biotechnology contributes to improving animal productivity by boosting growth, reproductive quality, nutrition, feed utilization, food safety, and other factors for a more efficient use of resources. As an illustration, in May 2023, the Humane Society launched the More Than a Pet campaign, highlighting the importance of equitable access to veterinary care, particularly for underserved communities. Through this initiative, over 14,800 pets received 64,000 services in 2023 via community outreach programs aimed at enhancing animal welfare in low-resource areas. The campaign is focused on delivering essential veterinary care and support to improve the well-being of animals in underserved regions. Thus, the growing awareness regarding animal health and welfare is driving the expansion of the animal biotechnology market.

How Is The Animal Biotechnology Market Classified Into Different Segments?

The animal biotechnology market covered in this report is segmented –

1) By Product Type: Diagnostics Tests, Vaccines, Drugs, Reproductive And Genetic, Feed Additives

2) By Animal Type: Companion, Livestock

3) By Application: Diagnosis Of Animal Diseases, Treatment Of Animal Diseases, Preventive Care Of Animals, Drug Development, Other Applications

4) By End-Use: Laboratories, Point-Of-Care Testing Or In-house Testing, Veterinary Hospitals And Clinics, Other End-Uses

Subsegments:

1) By Diagnostics Tests: Immunodiagnostic Tests, Molecular Diagnostic Tests, Biochemical Diagnostic Tests

2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

3) By Drugs: Antimicrobial Drugs, Anti-Inflammatory Drugs, Hormonal Drugs

4) By Reproductive And Genetic: Genetic Testing Services, Artificial Insemination Products, Embryo Transfer Technologies

5) By Feed Additives: Probiotics, Enzymes, Nutraceuticals

Which Competitive Trends Are Defining The Animal Biotechnology Market Structure?

Product innovation stands out as a significant trend within the animal biotechnology market. Key market participants are concentrating their efforts on creating novel products, exemplified by the application of virus-like particle (VLP) technology in vaccine development. For example, in April 2022, Cadila Pharmaceuticals, an India-based multinational pharmaceutical company, launched ThRabis, a three-dose rabies vaccine developed using virus-like particle technology for rabies. Virus-like particles (VLPs) describe a vaccine creation method that utilizes multiprotein structures to replicate the shape and size of a virus particle, but without containing the viral genome, which potentially leads to safer and more cost-effective vaccine candidates. ThRabis is composed of recombinant nanoparticle-based rabies G protein, which elicits antibodies against the rabies G protein to neutralize the virus and hinder its attachment to cells, thereby providing protection against rabies.

Who Are The Prominent Global Companies Shaping The Animal Biotechnology Market?

Major companies operating in the animal biotechnology market are Zoetis Inc., Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., IDEXX Laboratories Inc., IDVet, Heska Corporation, INDICAL BIOSCIENCE GmbH, BioChek BV, Ceva Santé Animale, Dalan Animal Health, Vetigenics, Vetoquinol S.A., Neogen Corporation, Abaxis Inc., Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Phibro Animal Health Corporation, Novartis Animal Health, Bayer AG, Bioniche Life Sciences Inc., Bio-Rad Laboratories Inc., Biovet JSC, Bovogen Biologicals Pty Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report

How Do Regional Market Performances Compare Within The Animal Biotechnology Industry?

North America was the largest region in the animal biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Animal Biotechnology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8059&type=smp

Browse Through More Reports Similar to the Global Animal Biotechnology Market 2025, By The Business Research Company

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Pain Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795